JB Chemicals & Pharmaceuticals: JB Pharma open to more buys to grow branded biz share
JB Chemicals & Pharmaceuticals (JB Pharma), controlled by US private equity firm KKR, is evaluating assets for acquisitions to strengthen its market share in the domestic branded formulation business. CEO Nikhil Chopra said the assets should be at the right valuation and have synergy with the existing business, with a payback period of seven to eight years.
Nikhil Chopra Rantac Ranitidine Cilacar Cilnidipine Jb Chemicals Pharmaceuticals Pharma Biocon Biologic Jb Chemicals Amp Pharmaceuticals
Source: indiatimes.com